Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Weizmann Institute researchers identify a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free...
Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission
If larger studies confirm the results of a Weizmann Institute innovation, diagnosing cancer may one day be as easy as taking blood
...How tumors mutate their way out of a crisis – and become drug resistant in the process
Weizmann Institute scientists solve the riddle of how RNA molecules get to their designated locations
Without cells that spur on the specialized antifungal units, the fight against a common infection is a lost cause
Blood vessels originating from lymphatic vessels were found to be tailored to specific functions